[Federal Register Volume 87, Number 243 (Tuesday, December 20, 2022)]
[Notices]
[Pages 77852-77853]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-27543]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Commission on Childhood Vaccines Meeting

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, this 
notice announces that the Advisory Commission on Childhood Vaccines 
(ACCV) will hold public meetings for the 2023 calendar year (CY). 
Information about the ACCV, agendas, and materials for these meetings 
can be found on the ACCV website at https://www.hrsa.gov/advisory-committees/vaccines/index.html.

DATES: The ACCV meetings will be held on:
     March 1, 2023, 10:00 a.m. Eastern Time (ET)-4:00 p.m. ET;
     March 2, 2023, 10:00 a.m. ET-4:00 p.m. ET;
     September 6, 2023, 10:00 a.m. ET-4:00 p.m. ET; and
     September 7, 2023, 10:00 a.m. ET-4:00 p.m. ET.

ADDRESSES: Meetings may be held in-person or by Zoom webinar. For 
updates on how the meeting will be held, visit the ACCV website 30 
business days before the date of the meeting, where instructions for 
joining meetings either in-person or remotely will be posted. In-person 
ACCV meetings will be held at 5600 Fishers Lane, Rockville, Maryland 
20857. For meeting information updates, go to the ACCV website meeting 
page at https://www.hrsa.gov/advisory-committees/vaccines/meetings.html.

FOR FURTHER INFORMATION CONTACT: Pita Gomez, Principal Staff Liaison, 
Division of Injury Compensation Programs, HRSA, 5600 Fishers Lane, 
08N186B, Rockville, Maryland 20857; 301-945-9386; or [email protected].

SUPPLEMENTARY INFORMATION: The ACCV provides advice and recommendations 
to the Secretary of HHS (Secretary) on policy, program development, and 
other

[[Page 77853]]

issues related to implementation of the National Vaccine Injury 
Compensation Program and concerning other matters as described under 
section 2119 of the Public Health Service Act (42 U.S.C. 300aa-19).
    Since priorities dictate meeting times, be advised that start 
times, end times, and agenda items are subject to change. Refer to the 
ACCV website listed above for any meeting updates that may occur. For 
CY 2023 meetings, agenda items may include, but are not limited to: 
updates from the Division of Injury Compensation Programs, Department 
of Justice, Office of Infectious Disease and HIV/AIDS Policy (HHS), 
Immunization Safety Office (Centers for Disease Control and 
Prevention), National Institute of Allergy and Infectious Diseases 
(National Institutes of Health) and Center for Biologics, Evaluation 
and Research (Food and Drug Administration). Refer to the ACCV website 
listed above for all current and updated information concerning the CY 
2023 ACCV meetings, including draft agendas and meeting materials that 
will be posted 5 calendar days before the meeting.
    These meetings are open to the public. Meetings held by Zoom 
webinar will require registration. Registration details will be 
provided on the ACCV website at https://www.hrsa.gov/advisory-committees/vaccines/meetings.html. All registrants will be asked to 
provide their name, affiliation, and email address. After registration, 
individuals will receive personalized Zoom information via email.
    Members of the public will have the opportunity to provide 
comments. Public participants may submit written statements in advance 
of the scheduled meeting(s). Oral comments will be honored in the order 
they are requested and may be limited as time allows. Requests to 
submit a written statement or make oral comments to the ACCV should be 
sent to Pita Gomez using the contact information above at least 5 
business days before the meeting date(s).
    Individuals who need special assistance or another reasonable 
accommodation should notify Pita Gomez using the contact information 
listed above at least 10 business days before the meeting(s) they wish 
to attend. If an in-person meeting is held, it will occur in a federal 
government building, and attendees must go through a security check to 
enter the building. Non-U.S. citizen attendees must notify HRSA of 
their planned attendance at least 20 business days prior to the meeting 
in order to facilitate their entry into the building. All attendees are 
required to present government-issued identification prior to entry.

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022-27543 Filed 12-19-22; 8:45 am]
BILLING CODE 4165-15-P